• Akira S, Takeda K & Kaisho T (2001) Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2: 675680.
  • Bernasconi NL, Onai N & Lanzavecchia A (2003) A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells. Blood 101: 45004504.
  • Bodey GP (1988) The emergence of fungi as major hospital pathogens. J Hosp Infect 11 (suppl A), 411426.
  • Cenci E, Mencacci A, Del Sero G et al. (1999) Interleukin-4 causes susceptibility to invasive pulmonary aspergillosis through suppression of protective type I responses. J Infect Dis 180: 19571968.
  • Dimitrova P & Ivanovska N (2006) Host resistance to Candida albicans infection of mice with collagen-induced arthritis treated with leflunomide. Res Microbiol 157: 525530.
  • Dimopoulos G, Karabinis A, Samonis G & Falagas ME (2007) Candidemia in immunocompromised and immunocompetent critically ill patients: a prospective comparative study. Eur J Clin Microbiol Infect Dis 26: 377384.
  • Gazit A, Yaish P, Gilon C & Levitzki A (1989) Tyrphostins I: synthesis and biological activity of protein tyrosine kinase inhibitors. J Med Chem 32: 23442352.
  • Grumont RJ, Rourke IJ, O'Reilly LA, Strasser A, Miyake K, Sha W & Gerondakis S (1998) B lymphocytes differentially use the Rel and nuclear factor kappaB1 (NF-kappaB1) transcription factors to regulate cell cycle progression and apoptosis in quiescent and mitogen-activated cells. J Exp Med 187: 663674.
  • Ho PP, Fontoura P, Ruiz PJ, Steinman L & Garren H (2003) An immunomodulatory GpG oligonucleotide for the treatment of autoimmunity via the innate and adaptive immune systems. J Immunol 171: 49204926.
  • Lipford GB, Heeg K & Wagner H (1998) Bacterial DNA as immune cell activator. Trends Microbiol 6: 496500.
  • Liu H (2002) Co-regulation of pathogenesis with dimorphism and phenotypic switching in Candida albicans, a commensal and a pathogen. Int J Med Microbiol 292: 299311.
  • Montagnoli C, Bacci A, Bozza S, Gaziano R, Mosci P, Sharpe AH & Romani L (2002) B7/CD28-dependent CD4+CD25+ regulatory T cells are essential components of the memory-protective immunity to Candida albicans. J Immunol 169: 62986308.
  • Puccetti P, Romani L & Bistoni F (1995) A TH1–TH2-like switch in candidiasis: new perspectives for therapy. Trends Microbiol 3: 237240.
  • Romani L (1999) Immunity to Candida albicans: Th1, Th2 cells and beyond. Curr Opin Microbiol 2: 363367.
  • Romani L, Mencacci A, Tonnetti L, Spaccapelo R, Cenci E, Wolf S, Puccetti P & Bistoni F (1994) Interleukin-12 but not interferon-gamma production correlates with induction of T helper type-1 phenotype in murine candidiasis. Eur J Immunol 24: 909915.
  • Sareila O, Korhonen R, Karpanniemi O, Nieminen R, Kankaanranta H & Moilanen E (2006) JAK inhibitors AG-490 and WHI-P154 decrease IFN-gamma-induced iNOS expression and NO production in macrophages. Mediat Inflamm 2006: 16161.
  • Stempelj M, Kedinger M, Augenlicht L & Klampfer L (2007) Essential role of the JAK/STAT1 signalling pathway in the expression of inducible nitric-oxide synthase in intestinal epithelial cells and its regulation by butyrate. J Biol Chem 282: 97979804.
  • Yordanov M, Dimitrova P, Danova S & Ivanovska N (2005) Candida albicans double-stranded DNA can participate in the host defense against disseminated candidiasis. Microbes Infect 7: 178186.